Proof The Bible Is True

Thanks! Share it with your friends!

• 

  Tweet

• 

  Share

• 

  Pin It

• 

  LinkedIn

• 

  Google+

• 

  Reddit

• 

  Tumblr

by Brian Shilhavy
Editor, Health Impact News

Merck’s Gardasil vaccine saw a 55% increase over last year’s third quarter, netting $1.05 billion in global sales for the third quarter of 2018.

Thanks to worldwide sales, the Gardasil vaccine has become the top money maker for Merck.

FiercePharma, the marketing trade publication for vaccine manufacturers, reports:

Merck’s Gardasil has been propelling the pharma giant’s vaccine unit in recent quarters, and that doesn’t look like it’ll be changing. The company sees more growth ahead thanks to an “unprecedented increase in worldwide demand” for HPV vaccines, an executive said.

Addressing the vaccine’s performance …read more

Source: Health Impact News